Al18F-NOTA-HER2-BCH Versus 18F-FDG PET/CT for Detecting Bone Metastases
Compared with 18 F-FDG PET/CT, Al 18 F-NOTA-HER2-BCH PET/CT demonstrated superior detection of bone metastases in HER2-positive breast cancer participants, particularly for early-stage CT-occult lesions and sub-centimeter (<10 mm) metastases. In addition, it showed potential for earlier identification of concurrent visceral metastases.
Authors
- Xiaoyi Guo (ORCID: https://orcid.org/0000-0002-0854-506X)
- Jiayue Liu (ORCID: https://orcid.org/0000-0002-7104-4874)
- Xiuli Ma
- Xu Liang
- Zhi Yang
- Chuangui Li
- Nina Zhou
- Huan Ma
- Hua Zhu
Institutions
- Hebei North University (CN)
- Peking University (CN)
- National Medical Products Administration (CN)
- Peking University Cancer Hospital (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1097/rlu.0000000000006249
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00